Cargando…

Oncologic Outcomes of Postoperative Chemoradiotherapy Versus Chemotherapy Alone in Stage II and III Upper Rectal Cancer

PURPOSE: The aim of this study was to assess oncological outcomes of postoperative radiotherapy plus chemotherapy (CRT) versus chemotherapy alone (CTx) in stage II or III upper rectal cancer patients who underwent curative surgery. METHODS: We retrospectively reviewed 263 consecutive patients with p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Ji Eun, Lee, Soo Young, Kwak, Han Duk, Yeom, Seung Seop, Kim, Chang Hyun, Joo, Jae Kyun, Kim, Hyeong Rok, Kim, Young Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Coloproctology 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625770/ https://www.ncbi.nlm.nih.gov/pubmed/31288502 http://dx.doi.org/10.3393/ac.2018.09.28

Ejemplares similares

Clinical Outcomes of Patients With Locally Advanced Rectal Cancer With Persistent Circumferential Resection Margin Invasion After Preoperative Chemoradiotherapy
por: Kim, Chang Hyun, et al.
Publicado: (2019)

Oncologic impact of pathologic response on clinical outcome after preoperative chemoradiotherapy in locally advanced rectal cancer
por: Yoon, Wook Hyeon, et al.
Publicado: (2015)

Clinical Significance of Tumor Regression Grade in Rectal Cancer with Preoperative Chemoradiotherapy
por: Park, Young Joo, et al.
Publicado: (2010)

Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis
por: Song, Changhoon, et al.
Publicado: (2015)

Impact of circumferential tumor location of mid to low rectal cancer on oncologic outcomes after preoperative chemoradiotherapy
por: Park, Hyeong-min, et al.
Publicado: (2022)

Postoperative Adjuvant Chemoradiotherapy Versus Chemotherapy Alone for Stage III Endometrial Cancer: A Multicenter Retrospective Study
por: Yoo, Ji Geun, et al.
Publicado: (2022)

The Relationship Between High-Output Stomas, Postoperative Ileus, and Readmission After Rectal Cancer Surgery With Diverting Ileostomy
por: Lee, Naa, et al.
Publicado: (2021)

Clinical Significance of Serial Serum Carcinoembryonic Antigen Values for Treating Rectal Cancer with Preoperative Chemoradiotherapy
por: Ryu, Young Jae, et al.
Publicado: (2012)

Association between microsatellite instability and tumor response to neoadjuvant chemoradiotherapy for rectal cancer
por: Lee, Soo Young, et al.
Publicado: (2022)

Factors Associated With Oncologic Outcomes Following Abdominoperineal or Intersphincteric Resection in Patients Treated With Preoperative Chemoradiotherapy: A Propensity Score Analysis
por: Kim, Chang Hyun, et al.
Publicado: (2015)

The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy
por: Yeom, Seung-Seop, et al.
Publicado: (2020)

Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy
por: Koo, Taeryool, et al.
Publicado: (2015)

Matched case-control analysis comparing oncologic outcomes between preoperative and postoperative chemoradiotherapy for rectal cancer
por: Lee, Byoung Chul, et al.
Publicado: (2017)

Is radical surgery for clinical stage I right-sided colon cancer relevant? A retrospective review
por: Kwak, Han Deok, et al.
Publicado: (2020)

Obesity as an independent predictive factor for pathologic complete response after neoadjuvant chemoradiation in rectal cancer
por: Lee, Soo Young, et al.
Publicado: (2019)

Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level: A Useful Tool for Prediction of Distant Metastasis in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision
por: Kim, Chang Hyun, et al.
Publicado: (2015)

Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II–III resectable rectal cancer: a meta-analysis of randomized controlled trials
por: Song, Jin Ho, et al.
Publicado: (2017)

Chemoradiotherapy versus radiotherapy alone following induction chemotherapy for elderly patients with stage III lung cancer
por: Kim, Dong-Yun, et al.
Publicado: (2019)

Tailored treatment of anastomotic leak after rectal cancer surgery according to the presence of a diverting stoma
por: Kim, Chang Hyun, et al.
Publicado: (2020)

Interim analysis of postoperative chemoradiotherapy with capecitabine and oxaliplatin versus capecitabine alone for pathological stage II and III rectal cancer: a randomized multicenter phase III trial
por: Feng, Yan-Ru, et al.
Publicado: (2016)

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma
por: Kim, Young-Il, et al.
Publicado: (2013)

Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
por: Lee, Sung Uk, et al.
Publicado: (2013)

Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
por: Lee, Joo Ho, et al.
Publicado: (2011)

Effect of preoperative immunonutrition on outcomes of colon cancer surgery: study protocol for a randomized controlled trial
por: Lee, Soo Young, et al.
Publicado: (2020)

Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer
por: Jeong, Jae-Uk, et al.
Publicado: (2016)

Prognostic significance of lymph node yield on oncologic outcomes according to tumor response after preoperative chemoradiotherapy in rectal cancer patients
por: Ryu, Hyo Seon, et al.
Publicado: (2023)

Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor
por: Kim, Hakyoung, et al.
Publicado: (2019)

Oncologic Outcomes of Organ Preserving Approaches in Patients With Rectal Cancer Treated With Preoperative Chemoradiotherapy
por: Park, In Ja, et al.
Publicado: (2019)

Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?
por: Choi, Jung Pil, et al.
Publicado: (2017)

Oncologic comparison between nonradical management and total mesorectal excision in good responders after chemoradiotherapy in patients with mid-to-low rectal cancer
por: Lee, Ja Kyung, et al.
Publicado: (2021)

Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer
por: Imano, Nobuki, et al.
Publicado: (2020)

Reduced-Port Laparoscopic Surgery for Patients With Proximal Transverse Colon Cancer With Situs Inversus Totalis: A Case Report
por: Yeom, Seung-Seop, et al.
Publicado: (2018)

Comparison between preoperative and postoperative concurrent chemoradiotherapy for rectal cancer: an institutional analysis
por: Lee, Jeong Won, et al.
Publicado: (2013)

Postoperative Radiotherapy Alone Versus Chemoradiotherapy in Stage I-II Endometrial Carcinoma: An Investigational and Propensity Score Matching Analysis
por: Lee, Jong Hoon, et al.
Publicado: (2015)

Early Systemic Failure After Preoperative Chemoradiotherapy for the Treatment of Patients With Rectal Cancer
por: Choi, Taesun, et al.
Publicado: (2019)

Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques
por: Kim, Tae Hyung, et al.
Publicado: (2021)

Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer
por: Cho, Ick Joon, et al.
Publicado: (2023)

Laparoscopic Total Mesorectal Excision in a Rectal Cancer Patient with Situs Inversus Totalis
por: Huh, Jung Wook, et al.
Publicado: (2010)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical Trial
por: Li, Ning, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_686am3hj155q5lb93gfbs0argp